STAT11h
Dementia risk, higher than thought, requires a national strategy
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
HealthDay on MSN22h
New Criteria Developed for Appropriate Use of Amyloid, Tau PET
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
Daily Independent1d
New diagnostic criteria for LATE dementia offers hope for improved dementia care
LEXINGTON Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are at the forefront of advancing ...
New criteria developed for appropriate use of cognitive impairment imaging tools
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
news.meaww1d
Wendy Williams says she has ‘no idea’ what the 7 pills she takes daily in treatment facility do
In her call-in interview with 'The Breakfast Club', Wendy Williams offered an unfiltered glimpse into her current life ...
USC Study Exposes Hidden Culprit of Dementia in Brain’s Blood Vessels
A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...
Wendy Williams Says She Has ‘No Idea’ What the 7 Pills She Takes Daily in Treatment Facility Are For
The former radio and television host was placed under court-ordered guardianship in 2022. The arrangement was put into place ...
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
Dartmouth Health hopes to improve Alzheimer's care with new program
Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...
Alzheimer's Research UK3d
Widening the search for new dementia treatments
They'll answer your questions and highlight the ways we’re widening the search for new dementia treatments. Dr Emma Mead is from the Alzheimer’s Research UK Drug Discovery Alliance, where she leads ...
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...